Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Electrolyzed Water Spray Reduces the Number of Bacteria E-coli and an Attenuated Human Flu Virus on Human Hands

NCT05797103 is registered in ClinicalTrials.gov with Dove Medical Press Ltd as lead sponsor.

NCT NCT05797103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05797103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Electrolyzed Water Spray Reduces the Number of Bacteria E-coli and an Attenuated Human Flu Virus on Human Hands
Lead sponsor
Dove Medical Press Ltd
Phase
Not applicable
Overall status
Completed
Start date
January 29, 2023
Completion date
July 27, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial growth, novel influenza a (h1n1)